Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients
Clinical trial NCT05129462 · COMPLETED
Trial details
- NCT number
- NCT05129462
- Sponsor
- Hunan Province Tumor Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-05
- Primary completion
- 2021-09-05
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.